| Apr 15 |
Adamis Pharmaceuticals misses on revenue
|
| Apr 15 |
Adamis Pharmaceuticals Announces 2020 Financial Results and Business Update
|
| Apr 15 |
Earnings Scheduled For April 15, 2021
|
| Apr 14 |
Adamis Pharmaceuticals: Upcoming Catalysts Support Speculative Buy
|
| Apr 13 |
Adamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2020 Financial Results Conference Call and Business Update
|
| Apr 12 |
Adamis Pharma To Resubmit Zimhi US Application For Opioid Overdose Soon
|
| Apr 12 |
Adamis Pharmaceuticals Provides an Update on ZIMHI™
|
| Mar 22 |
Will Adamis Pharmaceuticals (ADMP) Report Negative Q4 Earnings? What You Should Know
|
| Mar 15 |
Adamis Pharmaceuticals Announces Tempol Reduces Lung Inflammation in the COVID-19 Challenged Hamster Model
|
| Feb 22 |
Adamis gets FDA greenlight for tempol human studies in COVID-19
|
| Feb 22 |
Adamis Pharmaceuticals Cleared to Proceed with Human Studies of Tempol for the Treatment of COVID-19
|
| Feb 17 |
Adamis Pharma Shares Fall Despite US Patent Covering Naloxone
|
| Feb 17 |
Adamis strengthens patent portfolio for ZIMHI opioid overdose treatment
|
| Feb 17 |
Adamis Pharmaceuticals Strengthens Patent Portfolio for Its Naloxone Product Candidate
|
| Feb 9 |
70 Stocks Moving In Tuesday's Mid-Day Session
|
| Feb 9 |
105 Biggest Movers From Yesterday
|
| Feb 2 |
Adamis Pharmaceuticals Announces Closing of Public Offering of Common Stock
|
| Feb 1 |
88 Biggest Movers From Friday
|
| Jan 29 |
Adamis Pharmaceuticals (ADMP) trades sharply lower after pricing public offering
|
| Jan 28 |
Adamis Pharmaceuticals plunges in red after hours; stock offering on deck
|
| Jan 28 |
Adamis Pharmaceuticals and Human Immune Monitoring Center at Stanford University Announce Preliminary Tempol Data in Cells from COVID-19 Patients
|
| Jan 28 |
98 Biggest Movers From Yesterday
|
| Jan 26 |
Adamis provides update on potenital deal for its US compounding business
|
| Jan 26 |
Adamis Pharmaceuticals Provides Update On Its US Compounding Business
|
| Jan 24 |
Adamis Pharmaceuticals: Locking In Profits While Riding On The Back Of A Phoenix
|
